Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Price to Sales (2010 - 2013)

Updated

Kazia Therapeutics' (KZIA) Price to Sales stood at 10.36 in FY2025 (year ended Jun 30, 2025).

Analysis

Kazia Therapeutics (KZIA) Price to Sales (2010 - 2013) Analysis & Trends

Starting with FY2009, Kazia Therapeutics' Price to Sales history includes 15 fiscal years.

  • The FY2025 figure is the highest annual Price to Sales since FY2016.
  • Per Business Quant data, KZIA's Price to Sales was 0.77 in FY2024 and 2.30 in FY2021 (-74.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 4.66
Aug 30, 2013 4.00
Dec 31, 2012 3.19
Dec 31, 2011 0.97
Dec 31, 2010 1.25
API Access

Kazia Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=KZIA&period=max&api_key=YOUR_API_KEY